MoneyWorks4Me

Astec Lifesciences informs about statement of investor complaints

18 Oct 2017 Evaluate

Astec Lifesciences has informed about Statement of Investor Complaints as per Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Quarter ended 30th September, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
UPL 533.50
PI Industries 2188.80
Bayer CropScience 3640.30
Sharda Cropchem 725.05
Sumitomo Chem. India 404.75
View more..